IP Library › Granted Patent US 6,861,509
Granted Patent B1
US 6,861,509 · App. 09/489,407 · Granted Mar 1, 2005

Antibodies to Ret and RetL3

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,861,509
App. No.
09/489,407
Granted
Mar 1, 2005
Kind
B1
Abstract

Nucleotide and amino acid sequences are provided for compounds which promote tissue growth, as well as methods for modulating tissue growth, for imaging tissues and organs, and for treating patients.

Claims (4)

1. An isolated antibody that is produced by a hybridoma selected from the group consisting of AA.FF9 and AA.GE7.3.

2. An isolated antibody that binds to a polypeptide selected from the group consisting of (SEQ ID NO:15), (SEQ ID NO:17), (SEQ ID NO:19) and (SEQ ID NO:21).

3. A composition comprising (a) antibody according to claim 2 , conjugated to (b) a toxin, imageable compound or radionuclide.

4. The antibody of claim 2 , wherein the antibody binds to a polypeptide selected from the group consisting of (SEQ ID NO:19) and (SEQ ID NO:21).

Assignments (1)
CHANGE OF NAME Recorded May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →